APOGEN BIOTECHNOLOGIES
ApoGen Biotechnologies, Inc. is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constant nearly all cancer drug therapies eventually fail due to the development of drug resistance. Mutation of cellular DNA is central to the formation of cancer, and chronic mutation of the cancer genome is a primary cause of cancer evolution and drug resistance, resulting in ineffective therapy, cancer recurrence and metastasis, and decreased overall survival.
APOGEN BIOTECHNOLOGIES
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.apogenbiotech.com
Total Employee:
1+
Status:
Active
Contact:
(206)957-7300
Email Addresses:
[email protected]
Total Funding:
11 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta WordPress Google Maps SSL By Default IPv6 Cloudflare Hosting Wordpress Plugins Cloudflare CDN Cloudflare
Similar Organizations
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Immunotrex Biologics
Immunotrex Biologics is a biotechnology company focusing on novel molecular diagnostic devices as well as therapeutic strategies.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
M Ventures
M Ventures investment in Series A - ApoGen Biotechnologies
Alexandria
Alexandria investment in Series A - ApoGen Biotechnologies
ARCH Venture Partners
ARCH Venture Partners investment in Series A - ApoGen Biotechnologies
Johnson & Johnson Robotics and Digital Solutions
Johnson & Johnson Robotics and Digital Solutions investment in Series A - ApoGen Biotechnologies
WuXi AppTec
WuXi AppTec investment in Series A - ApoGen Biotechnologies
Watson Fund
Watson Fund investment in Series A - ApoGen Biotechnologies
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - ApoGen Biotechnologies
Eli Lilly
Eli Lilly investment in Series A - ApoGen Biotechnologies
Accelerator Corp.
Accelerator Corp. investment in Series A - ApoGen Biotechnologies
Washington Research Foundation
Washington Research Foundation investment in Series A - ApoGen Biotechnologies
Official Site Inspections
http://www.apogenbiotech.com
- Host name: 104.21.47.135
- IP address: 104.21.47.135
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ApoGen Biotechnologies"
ApoGen Biotechnologies, Inc. - Development of a New …
Breaking drug resistance in cancer through the development of a new class of therapies that target key drivers of ongoing DNA mutation and tumor evolution. Crypto tokens are revolutionizing the health sector by enabling secure, …See details»
ApoGen Biotechnologies - Crunchbase Company Profile & Funding
ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics.See details»
ApoGen Biotechnologies - Craft
ApoGen Biotechnologies has 5 employees at their 1 location and $11 m in total funding,. See insights on ApoGen Biotechnologies including office locations, competitors, revenue, …See details»
ApoGen Biotechnologies 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for ApoGen Biotechnologies. Use the PitchBook Platform to explore the full profile.See details»
ApoGen Biotechnologies, Inc. - Company Profile & Staff
ApoGen Biotechnologies is developing novel oncology therapeutics targeting the key drivers of mutation and cancer genomic evolution to overcome drug resistance. …See details»
Overview, News & Similar companies - ZoomInfo.com
Aug 23, 2018 View ApoGen Biotechnologies (www.apogenbiotech.com) location in Washington, United States , revenue, industry and description. Find related and similar companies as well …See details»
Apogen Biotechnologies, Inc. Company Profile | Saint Paul, MN ...
Find company research, competitor information, contact details & financial data for Apogen Biotechnologies, Inc. of Saint Paul, MN. Get the latest business insights from Dun & Bradstreet.See details»
Apogen Biotechnologies (USA) Funding: $11M
Apr 2, 2025 ApoGen Biotechnologies is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.As the arsenal of available cancer therapies has grown and evolved from cytotoxic …See details»
Apogen Biotechnologies, Inc. - Golden
Apogen Biotechnologies, Inc. is a company founded in 2014 by John Santini, Reuben Harris and Daniel Harki.See details»
ApoGen Biotechnologies, Inc. Overview | SignalHire Company Profile
ApoGen Biotechnologies, Inc. is a private company that has been in the industry for 9 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals, Biotechnology areasSee details»
Startup Profile: ApoGen Biotechnologies | RIO
Dec 4, 2014 Using his expertise in drug discovery and development, Harki is developing a treatment that can inhibit APOBEC, making future cancer treatments more effective. ApoGen …See details»
Apogen Biotech - 2025 Company Profile - Tracxn
Apr 21, 2025 Apogen Biotech - Developing cancer drug therapies to block a key enzyme APOBEC that causes drug resistance.. Raised a total funding of $11M over 2 rounds from 10 …See details»
ApoGen Biotechnologies Venture Capital and Private Equity …
ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics targeting drivers of cancer genomic mutation. ApoGen is building upon …See details»
ApoGen Biotechnologies Company Information - Funding, …
Get information on funding, investors, industries, and more for ApoGen Biotechnologies. See ApoGen Biotechnologies company profile and funding data.See details»
ApoGen Biotechnologies Expands Series A Financing to $11 …
Aug 23, 2018 Stephen Gwaltney and Peter de Vries Join Senior Scientific Management Team Seattle, WA – August 23, 2018 – ApoGen Biotechnologies, Inc., a company developing a new …See details»
Apogen Biotechnologies - VentureRadar
ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics targeting drivers of cancer genomic mutation. ApoGen is building upon …See details»
ApoGen Biotechnologies expands series A financing to $11m
ApoGen Biotechnologies, a biotechnology firm engaged in the development of a new class of therapeutics targeting drivers of cancer genomic mutations, has expanded its series A …See details»
ApoGen Biotechnologies Expands Series A Financing to $11 …
Aug 23, 2018 ApoGen Biotechnologies, Inc., a company developing a new class of drugs that target the underlying mechanisms that lead to the development of drug resSee details»
Apogen Biotechnologies - VentureRadar
Private Company "ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics targeting drivers of cancer genomic mutation. …See details»
Microsoft Word - ApoGen Draft Press Release redlined …
ApoGen’s drug discovery and development efforts are directed toward highly selective and potent small molecule inhibitors of the APOBEC family of enzymes, which are DNA cytosine …See details»